As a national peak organisation Hepatitis Australia is often called upon, or seeks to participate in high level national forums relevant to viral hepatitis. Some aspects of Australia's response to viral hepatitis are world leading and our role in the global response means we can also be called upon to participate in international events and forums.

Hepatitis Australia represents its members and communities of interest in the following forums:


  • Ministerial Advisory Committee on Blood Borne Viruses and Sexually Transmissible Infections (MACBBVS) - Australian Government Department of Health
  • Blood Borne Viruses and Sexually Transmitted Infections Standing Committee (BBVSS) - Australian Government Department of Health
  • BBV/STI Annual Surveillance Report (ASR) Advisory Committee - Kirby Institute
  • Hepatitis B and Hepatitis C Cascades Working Groups – Kirby Institute
  • WHO Collaborating Centre for Viral Hepatitis Epidemiology and Public Health Research Advisory Group - Doherty Institute
  • National Hepatitis B and Hepatitis C Testing Policy Expert Reference Groups - ASHM
  • Australian STI Management Guidelines for Use in Primary Care Reference Committee - ASHM
  • Strengthening Harm Reduction in Prisons Working Group – DPMP
  • National Prisons Hepatitis Network Executive Committee
  • Healthcare Providers Program Committee of the National Prisons Hepatitis Education Project
  • EC Australia Executive Committee - Burnet Institute
  • ACCESS Advisory Committee (Network Project) - Burnet Institute, Kirby Institute & Doherty Institute
  • Advisory Group for the HBV Stigma Indicators Study – Centre for Social Research in Health, UNSW
  • Primary Care Collaborative Cancer Clinical Trials Group (PC4) Identifying Cirrhosis and Liver Cancer in Primary Care (IC3) Committee
  • Hepatitis B and Hepatitis C Consensus Statements Community Oversight Groups – GESA
  • Viral Hepatitis Conference Organising Committee – ASHM
  • Stigma and Discrimination Video Project Working Group – ASHM
  • Beyond the C National Steering Committee - ASHM
  • Roadmap to Liver Cancer Control, Guidelines Community Reference Group – Cancer Council


  • Member of the World Hepatitis Alliance
  • ICE-HBV Stakeholders Group
  • Member of the Vienna NGO Committee on Drugs
  • Member of the International Network on Health and Hepatitis in Substance Users (INHSU)

Page updated: 12 September 2022